Sean F. Scanlan, SVP, Marketing at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 50,000 shares at $20.16 ($1.0M) on 2022-02-09, disclosed to the SEC on 2022-02-10.
Open-market sale of $1.0M TMCI by SVP, Marketing. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.02 | 21,127 | $423K | 42.2% |
| 2 | $20.02 | 21,127 | $423K | 42.2% |
| 3 | $20.16 | 3,873 | $78K | 7.8% |
| 4 | $20.16 | 3,873 | $78K | 7.8% |
| Total | $20.04 avg | 50,000 | $1.0M | 100% |
| Filing → |
| TMCI | SELL | 2023-03-10 | $12K | — | Filing → |
| TMCI | SELL | 2023-02-17 | $542K | — | Filing → |
| TMCI | SELL | 2023-01-13 | $639K | — | Filing → |